Literature DB >> 20211824

Medication nonadherence secondary to drug-induced memory loss.

Ann Marie Nye1, Valerie B Clinard, Connie L Barnes.   

Abstract

Overactive bladder (OAB) is a common condition in the elderly. Treatments for OAB include nonpharmacological or behavioral therapy, pharmacological therapy, and surgical therapy. Antimuscarinic agents are the current pharmacological treatment for OAB and are known to cause memory impairment. A 66-year-old female presented with memory loss secondary to the administration of oxybutynin, which resulted in medication nonadherence. Upon review of her medications, the pharmacist recommended discontinuing the oxybutynin because of the anticholinergic effects on cognition. At a three-week follow-up visit, the patient reported an improvement in memory and medication adherence. Pharmacists can play a vital role in recognizing drug-induced side effects and educating patients in an effort to improve medication adherence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211824     DOI: 10.4140/TCP.n.2010.117

Source DB:  PubMed          Journal:  Consult Pharm        ISSN: 0888-5109


  5 in total

Review 1.  Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder.

Authors:  Michael B Chancellor; David R Staskin; Gary G Kay; Bobby W Sandage; Michael G Oefelein; Jack W Tsao
Journal:  Drugs Aging       Date:  2012-04-01       Impact factor: 3.923

Review 2.  Antimuscarinics for the treatment of overactive bladder: understanding the role of muscarinic subtype selectivity.

Authors:  Karin Glavind; Michael Chancellor
Journal:  Int Urogynecol J       Date:  2011-04-06       Impact factor: 2.894

Review 3.  Managing Urinary Incontinence in Patients with Dementia: Pharmacological Treatment Options and Considerations.

Authors:  Susie Orme; Vikky Morris; William Gibson; Adrian Wagg
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

4.  Overactive bladder: the importance of tailoring treatment to the individual patient.

Authors:  Harold P Drutz
Journal:  J Multidiscip Healthc       Date:  2011-07-22

5.  Cognitive Function before and during Treatment with Selective Serotonin Reuptake Inhibitors in Patients with Depression or Obsessive-Compulsive Disorder.

Authors:  Mehdi Sayyah; Kaveh Eslami; Shabnam AlaiShehni; Leila Kouti
Journal:  Psychiatry J       Date:  2016-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.